相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential sensitivities of triple-negative breast cancer stem cell towards various doses of vitamin C: An insight into the internal antioxidant systems
Utsav Sen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma
Qing Li et al.
CANCER LETTERS (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer
Jiayu Sheng et al.
CURRENT MOLECULAR MEDICINE (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics
A. J. Lucanus et al.
ONCOGENE (2018)
Timing and Delays in Breast Cancer Evaluation and Treatment
Richard J. Bleicher
ANNALS OF SURGICAL ONCOLOGY (2018)
PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer
Zhiwang Song et al.
GENE (2018)
Creating prognostic systems for cancer patients: A demonstration using breast cancer
Mathew T. Hueman et al.
CANCER MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
Boxi Zhang et al.
CELL REPORTS (2017)
The importance of serine metabolism in cancer
Katherine R. Mattaini et al.
JOURNAL OF CELL BIOLOGY (2016)
Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
Xiao-qin Jia et al.
TRANSLATIONAL ONCOLOGY (2016)
Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
Judith E. Unterlass et al.
Oncotarget (2016)
The chicken chorioallantoic membrane model in biology, medicine and bioengineering
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2014)
Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer
N. Patani et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Phosphoglycerate Dehydrogenase: Potential Therapeutic Target and Putative Metabolic Oncogene
Cheryl K. Zogg
JOURNAL OF ONCOLOGY (2014)
Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
Noor A. Lokman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato et al.
NATURE (2011)
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale et al.
NATURE GENETICS (2011)
PHGDH amplification and altered glucose metabolism in human melanoma
Edouard Mullarky et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Markus Ringner et al.
PLOS ONE (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors
Chuay-Yeng Koo et al.
MODERN PATHOLOGY (2006)
Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998
CI Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
